REGENXBIO Inc.RGNXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank67
3Y CAGR-7.8%
5Y CAGR+1.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.8%/yr
vs +27.7%/yr prior
5Y CAGR
+1.1%/yr
Recent deceleration
Acceleration
-35.5pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $251.34M | -11.2% |
| 2024 | $283.11M | -11.8% |
| 2023 | $321.16M | +0.0% |
| 2022 | $321.06M | +24.2% |
| 2021 | $258.53M | +8.6% |
| 2020 | $238.09M | +35.3% |
| 2019 | $175.99M | +45.7% |
| 2018 | $120.77M | +42.8% |
| 2017 | $84.57M | +22.6% |
| 2016 | $68.97M | - |